Mini-proinsulin and Mini-IGF-I: Homologous protein sequences encoding non-homologous structures

Journal of Molecular Biology

Volumn 277, Issue 1, 1998, Pages 103-118

  Hua, Qing Xin ^a   Hu, Shi Quan ^b   Jia, Wenhua ^a   Chu, Ying Chi ^b   Burke, G Thompson ^b   Wang, Shu Hua ^b   Wang, Run Ying ^b   Katsoyannis, Panayotis G ^b   Weiss, Michael A ^a,c  

^a Center for Molecular Oncology   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Insulin; Insulin receptor; NMR; Protein folding; Transmembrane signaling

Indexed keywords

INSULIN RECEPTOR; PROINSULIN; SOMATOMEDIN C;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CHEMICAL BOND; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; HYDROPHOBICITY; MOLECULAR MODEL; PEPTIDE BOND; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; RECEPTOR AFFINITY;

EID: 0032549666     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1574     Document Type: Article

References (85)

1. Ahmed A.K., Schaffer S.W., Wetlaufer D.B. Nonenzymic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers. J. Biol. Chem. 250:1975;8477-8482
2. Badger J. Flexibility in crystalline insulins. Biophys. J. 61:1992;816-819
3. Baker E.N.E.N., Blundell T.L., Cutfield J.F., Cutfield S.M., Dodson G.G., Hodgkin D.M.C., Hubbard R.E., Isaacs M.W., Reynolds C.D., Sakabe K., Sakabe N., Vijayan N.M. The structure of 2-Zn pig insulin crystals at 1.5 Å resolution. Phil. Trans. Roy. Soc. ser. B. 319:1988;369-456
4. Barany G., Merrifield R.B. Gross E., Meienhofer J. The Peptides. vol. 2:1979;3-284 Academic Press Ltd, New York
5. Bentley G., Dodson G., Lewitova A. The rhombohedral insulin crystal transformation. J. Mol. Biol. 126:1978;871-875
6. Blundell T.L., Dodson G.G., Hodgkin D.C., Mercola D.A. Insulin the structure in the crystal and its reflection in chemistry and biology. Advan. Protein Chem. 26:1972;279-402
7. Bowie J.U., Luthy R., Eisenberg D. A method to identify protein sequences that fold into a known three-dimensional structure. Science. 253:1990;164-170
8. Brandenburg D., Gattner H.-G., Wollmer A. Preparation and properties of acetyl derivatives of beef insulin. I. Hoppe-Seyler's Z. Physiol. Chem. 353:1972;599-617
9. Brandenburg D., Biela M., Herbertz L., Zahn H. Partial synthesis and properties of des-A1-glycine-insulin. Hoppe-Seyler's Z. Physiol. Chem. 356:1975;961-979
10. Brange J., Ribel U., Hansen J.F., Dodson G., Hansen M.T., Havelund S., Melberg S.G., Norris F., Norris K., Snel L. Monomeric insulins obtained by protein engineering and their medical implications. Nature. 333:1988;679-682
11. Brems D.N., Brown P.L., Nakagawa S.H., Tager H.S. The conformational stability and flexibility of insulin with an additional intramolecular cross-link. J. Biol. Chem. 266:1991;1611-1615
12. Brems D.N., Alter L.A., Beckage M.J., Chance R.E., DiMarchi R.D., Green L.K., Long H.B., Pekar A.H., Shields J.E., Frank B.H. Altering the association properties of insulin by amino acid replacement. Protein Eng. 5:1992;527-533
13. Brünger A.T. X-PLOR. 1992;Yale University Press, New Haven, CT
14. Bryson J.W., Betz S.F., Lu H.S., Suich D.J., Zhou H.X., O'Neil K.T., DeGrado W.F. Protein design a hierarchic approach. Science. 270:1995;935-941
15. Chance R.E., Hoffman J.A., Kroeff E.P., Johnson M.G., Schirmer W.E., Bormer W.W. The production of human insulin using recombinant DNA technology and a new chain recombination procedure. Rich D.H., Gross E. Peptides Proceedings of the Seventh American Peptide Symposium. 1981;721-728 Pierce Chemical Co, Rockford, IL
16. Chothia C., Lesk A.M., Dodson G.G., Hodskin D.C. Transmission of conformational change in insulin. Nature. 302:1983;500-505
17. B29-human insulin. Structure. 3:1995;615-622
18. Cosmatos A., Cheng K., Okada H., Katsoyannis P.G. The chemical synthesis and biological evaluation of [1-L-alanine-A]-and 1-D-alanine-A]-insulins. J. Biol. Chem. 253:1978;6586-6590
19. Cosmatos A., Ferderigos N., Katsoyannis P.G. Chemical synthesis of [des(tetrapeptide B27-30), Tyr(NH2)26-B] and [des(pentapeptide B26-30), Phe(NH2)25-B] bovine insulins. Int. J. Pep. Protein Res. 14:1979;457-471
20. Dai J.-B., Lou M.-Z., You J.-M., Liang D.-C. Refinement of the structure of despentapetide (B26-B30) insulin at 1.5 Å resolution. Sci. Sin. 30:1988;55-65
21. Dalal S., Balasubramanian O., Regan L. Protein alchemy changing β-sheet into α-helix. Nature Struct. Biol. 4:1997;548-552
22. Derewenda U., Derewenda Z., Dodson E.J., Dodson G.G., Reynolds C., Smith G.D., Sparks C., Swenson D. Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer. Nature. 338:1989;594-596
23. Derewenda U., Derewenda Z., Dodson E.J., Dodson G.G., Bing X.G., Markussen J. The X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule a completely inactive analogue. J. Mol. Biol. 220:1991;425-433
24. DeWolf E., Gill R., Geddes S., Pitts J., Wollmer A., Grotzinger J. Solution structure of a mini IGF-1. Protein Sci. 5:1996;2193-2202
25. DiMarchi R.D., Mayer J.P., Fan L., Brems D.N., Frank B.H., Green L.K., Hoffman J.A., Howey D.C., Long H.B., Shaw W.N., Shields J.E., Slieker L.J., Su K.S.E., Sundell K.L., Chance R.E. Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factror I. Smith J.A., Rivier J.E. Peptides Proceedings of the Twelfth American Peptide Symposium. 1992;26-28 ESCOM Science Publishers B. V, Leiden, The Netherlands
26. Drewes S.E., Magojo H.E., Gliemann J. NA1, NA1, NA1-trimethylinsulin an insulin analogue with a quaternary amino group at the A1 terminus. Hoppe-Seylers Z. Physiol. Chem. 362:1981;745-753
27. Frank B.H., Chance R.E. Two routes for producing human insulin utilizing recombinant DNA technology. MMW: Munchener Medizinische Wochenschrift. (Suppl. 1):1993;S14-S20
28. Galloway J.A., Chance R.E. Improving insulin therapy achievements and challenges. Hormone Metabol. Res. 26:1994;591-598
29. Gill R., Wallach B., Verma C., Urso B., De Wolf E., Grotzinger J. Engineering the C-region of human insulin-like growth factor-1 implications for receptor binding. Protein Eng. 9:1996;1011-1019
30. Goldman J., Carpenter F.H. Zinc binding, circular dichroism, and equilibrium sedimentation studies of insulin (bovine) and several of its derivatives. Biochemistry. 13:1974;4566-4574
31. Hagenmaier H., Frank H. Increased coupling yields in solid-phase peptide synthesis with a modified carbodiimide coupling procedure. Hoppe-Seylers Z. Physiolo. Chem. 353:1972;1973-1976
32. Havel T.F. An evaluation of computational strategies for use in the determination of protein structure from distance constraints obtained by nuclear magnetic resonance. Prog. Biophys. Mol. Biol. 56:1991;43-78
33. Hober S., Forsberg G., Palm G., Hartmanis M., Nilsson B. Disulfide exchange folding of insulin-like growth factor I. Biochemistry. 31:1992;1749-1756
34. Hober S., Hansson A., Uhlen M., Nilsson B. Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein. Biochemistry. 33:1994;6758-6761
35. Hu S.-Q., Burke G.T., Schwartz G.P., Ferderigos N., Ross J.B., Katsoyannis P.G. Steric requirements at position B12 for high biological activity in insulin. Biochemistry. 32:1993;2631-2635
36. Hua Q.-X., Weiss M.A. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin sequential resonance assignment and implications for protein dynamics and receptor recognition. Biochemistry. 30:1991;5505-5515
37. Hua Q.-X., Shoelson S.E., Kochoyan M., Weiss M.A. Receptor binding redefined by a structural switch in a mutant human insulin. Nature. 354:1991;238-241
38. Hua Q.-X., Shoelson S.E., Inouye K., Weiss M.A. Paradoxial structure and function in a mutant human insulin associated with diabetes mellitus. Proc. Natl. Acad. Sci. USA. 90:1993;582-586
39. Hua Q.-X., Jia W., Frank B.H., Weiss M.A. Comparison of the dynamics of an engineered insulin monomer and dimer by acid-quenched amide proton exchange Non-local stabilization of the interchain hydrogen bonds by dimerization. J. Mol. Biol. 230:1993;387-394
40. Hua Q.-X., Gozani S.N., Chance R.E., Hoffmann J.A., Frank B.H., Weiss M.A. Structure of a protein in a kinetic trap. Nature Struct. Biol. 2:1995;129-138
41. Hua Q.-X., Narhi L., Jia W., Arakawa T., Rosenfeld R., Hawkins N., Miller J.A., Weiss M.A. Native and non-native structure in a protein-folding intermediate spectroscopic studies of partially reduced IGF-I and an engineered alanine model. J. Mol. Biol. 259:1996;297-313
42. Hua Q.X., Hu S.Q., Frank B.H., Jia W., Chu Y.C., Wang S.H., Burke G.T., Katsoyannis P.G., Weiss M.A. Mapping the functional surface of insulin by design structure and function of a novel A-chain analogue. J. Mol. Biol. 264:1996;390-403
43. Jørgensen A.M.M., Kristensen S.M., Led J.J., Balschmidt P. Three-dimensional solution structure of an insulin dimer. A study of the B9(Asp) mutant of an human insulin using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics. J. Mol. Biol. 227:1992;1146-1163
44. Katsoyannis P.G. Synthesis of insulin. Science. 154:1966;1509-1514
45. Katsoyannis P.G., Tometsko A., Zalut C., Johnson S., Trakatellis A.C. Studies on the synthesis of insulin from natural and synthetic A and B chains. I. Splitting of insulin and isolation of the S-sulfonated derivatives of the A and B chains. Biochemistry. 6:1967;2635-2642
46. Katsoyannis P.G., Trakatellis A.C., Zalut C., Johnson S., Tometsko A., Schwartz G., Ginos J. Studies on the synthesis of insulin from natural and synthetic A and B chains. 3. Synthetic insulins. Biochemistry. 6:1967;2656-2668
47. Kim Y., Prestegard J.H. Refinement of the NMR structures for acyl carrier protein with scalar coupling data. Proteins: Struct. Funct. Genet. 8:1990;377-385
48. 2amino acid residue in the biological activity of insulin [2-glycine-A] and [2-alanine-A]-insulins. Biochemistry. 23:1984;1405-1413
49. 1H-NMR assignments for human insulin. Biochemistry. 29:1990;2906-2913
50. Kobayashi M., Ohgaku S., Iwasaki M., Maegawa H., Shigeta Y., Inouye K. Supernormal insulin (D-PheB24) insulin with increased affinity for insulin receptors. Biochem. Biophys. Res. Commun. 107:1982;329-336
51. A3]-insulin. Biochem. Biophys. Res. Commun. 137:1986;250-257
52. Kruger P., Hahnen J., Wollmer A. Comparative studies on the dynamics of crosslinked insulin. Eur. Biophys. J. 23:1994;177-187
53. Liang D.C., Chang W.R., Zhang J.P., Wan Z.L. The possible mechanism of binding interaction of insulin molecule with its receptor. Sci. China, ser. B. 35:1992;547-557
54. Ludvigsen S., Roy M., Tørgersen H., Kaarsholm N.C. High-resolution structure of an engineered biologically potent insulin monomer, B16 Tyr→His, as determined by nuclear magnetic resonance spectroscopy. Biochemistry. 33:1994;7998-8006
55. Luthy R., Bowie J.U., Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 356:1991;83-85
56. Markussen J. Comparative reduction/oxidation studies with single chain des-(B30) insulin and porcine proinsulin. Int. J. Pept. Protein. Res. 25:1985;431-434
57. Markussen J. Single-chain des-(B30) insulin. Int. J. Pept. Protein Res. 26:1985;70-77
58. Markussen J., Hougaar P., Ribel U., Sorensen A.S., Sorensen E. Soluble, prolonged-acting insulin derivatives. I. Degree of protraction and crystallizability of insulins substituted in the terminal of the B-chain. Protein Eng. 1:1987;205-213
59. Markussen J., Diers I., Hougaard P., Langkjaer L., Norris K., Snel L., Sorensen A.R., Sorensen E., Voigt H.O. Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability, and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30. Protein Eng. 2:1988;157-166
60. Merrifield R.B., Vizioli L.D., Boman H.G. Synthesis of the antibacterial peptide cecropin A (1-33). Biochemistry. 21:1982;5020-5031
61. Miller J.A., Narhi L., Hua Q.-X., Rosenfeld R., Arakawa T., Rohde M., Prestrelski S., Lauren S., Stoney K.S., Tsai L., Weiss M.A. Oxidative refolding of insulin-like growth factor 1 yields two products of similar thermodynamic stability a bifurcating protein-folding pathway. Biochemistry. 32:1993;5203-5213
62. Mirmira R., Tager H.S. Role of the phenylalanine B24 side-chain in directing insulin interaction with its receptor. J. Biol. Chem. 264:1989;6349-6354
63. Nakagawa S.H., Tager H.S. Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29. J. Biol. Chem. 264:1989;272-279
64. Nakagawa S.H., Tager H.S. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions. Biochemistry. 31:1992;3204-3214
65. Narhi L.O., Hua Q.-X., Arakawa T., Fox G.M., Tsai L., Rosenfeld R., Holst P., Miller J.A., Weiss M.A. Role of native disulfide bonds in the structure and activity of insulin-like growth factor I (IGF-1) genetic models of protein-folding intermediates. Biochemistry. 32:1993;5214-5221
66. Olsen H.B., Ludvigsen S., Kaarsholm N.C. Solution structure of an engineered insulin monomer at neutral pH. Biochemistry. 35:1996;8836-8845
67. Pullen R.A., Lindsay D.G., Wood S.P., Tickle I.J., Blundell T.L., Wollmer A., Krail G., Brandenburg D., Zahn H., Gliemann J., Gammeltoft S. Receptor-binding region of insulin. Nature. 259:1976;369-373
68. 1H NMR spectrum of the native human insulin monomer. J. Biol. Chem. 265:1990;5448-5453
69. A3]-insulin. Biochem. Biophys. Res. Commun. 137:1986;250-257
70. Shoelson S.E., Hua Q.-X., Lynch C.E., Weiss M.A. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions. Biochemistry. 31:1992;1757-1767
71. Sieber P.S., Eisler K., Kamber B., Riniker B., Rittel W., Marki F., deGasparo M. Synthesis and biological activity of two disulphide bond isomers of human insulin [A7-A11,A6-B7-cystine]-and [A6-A7,A11-B7-cystine]insulin (human). Hoppe-Seyler's Z. Physiol. Chem. 359:1978;113-123
72. Schwartz G.P., Burke G.T., Katsoyannis P.G. A superactive insulin [B10-aspartic acid]-insulin (human). Proc. Natl Acad. Sci. USA. 84:1987;6408-6411
73. 2]-insulin (human). Proc. Natl Acad. Sci. USA. 86:1989;458-461
74. Smith G.D., Dodson G.G. Structure of a rhombohedral R6 insulin/phenol complex. Proteins: Struct. Funct. Genet. 14:1992;401-408
75. Smith G.D., Ciszak E. The structure of a complex of hexameric insulin and 4′-hydroxyacetanilide. Proc. Natl Acad. Sci. USA. 91:1994;8851-8855
76. Steiner D.F., Chan S.J., Welsh J.M., Kwok S.C. Structure and evolution of the insulin gene. Annu. Rev. Genet. 19:1985;463-484
77. Steiner D.F., Bell G.I., Tager H.S. DeGroot L.J. Endocrinology. 1990;1263-1289 W. S. Saunders Co, Philadelphia, PA
78. Wan Z.L., Liang D.C. Studies on the crystal structure of A1-(D-Tryptophan) insulin. Sci. China. ser. B. 33:1990;810-820
79. Wang C.C., Tsou C.L. The insulin A and B chains contain sufficient structural information to form the native molecule. Trends Biochem. Sci. 16:1991;279-281
80. Wang S.H., Hu S.Q., Burke G.T., Katsoyannis P.G. Insulin analogues with modifications in the beta-turn of the B-chain. J. Protein Chem. 10:1991;313-324
81. 1H NMR with application to phage lambda repressor. Proc. Natl Acad. Sci. USA. 81:1984;6019-6023
82. Weiss M.A., Nguyen D.T., Khait I., Inouye K., Frank B.H., Beckage M., O'Shea E., Shoelson S.E., Karplus M., Neuringer L.J. Two-dimensional NMR and photo-CIDNP studies of the insulin monomer assignment of aromatic resonances with application to protein folding, structure, and dynamics. Biochemistry. 29:1989;9855-9873
83. 13C isotopic labeling with application to protein design. Biochemistry. 30:1991;7373-7389
84. Whittingham J.L., Chaudhuri S., Dodson E.J., Moody P.C., Dodson G.G. X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate, methylparaben, and phenol. Biochemistry. 34:1994;15553-15563
85. Wüthrich K. NMR of Proteins and Nucleic Acids. 1986;John Wiley and Sons, New York